Dr. Benjamin Winkeljann

Dr. Benjamin Winkeljann

RnHale

Benjamin Winkeljann is an engineer and entrepreneur, specializing in the development of drug delivery systems for RNA delivery and the optimization of pharmaceutical processes. He earned his Bachelor's and Master's degrees in Mechanical Engineering from the Technical University of Munich (TUM), Germany, and then proceeded to complete his PhD in bioengineering within TUM's Munich School of Bioengineering. Following a short postdoctoral phase at the same institution, he shifted his focus towards pharmaceutical technology by accepting a postdoctoral scientist position at the Ludwig-Maximilians-University Munich's Department for Pharmacy. Here, his work concentrated on simulation-assisted optimization for the formulation of RNA therapeutics. In 2023, he advanced to become a Group Leader and started pursuing a University Lecturer Qualification in Pharmaceutical Technology and Drug Delivery. In the same year, Winkeljann co-founded RNhale GmbH in Munich, where he currently serves as CEO.